Tattoos, lymphoma, and skin cancer: bioethical assessment

Tattoos have ceased to be a simple aesthetic expression and have become the object of growing scientific and health concerns.

New epidemiological studies link certain inks and their accumulation in the body to an increased risk of lymphoma and skin cancer, while researchers and authorities warn about the presence of heavy metals and potentially carcinogenic compounds in their pigments.

Given this scenario, the debate is no longer limited to fashion or aesthetic freedom, but raises important bioethical, regulatory and public health questions.

The practice of tattooing has experienced exponential growth, accompanied by widespread acceptance in contemporary society.

Historically, public health concerns and risks associated with tattoos focused almost exclusively on the possibility of transmission of infectious diseases such as hepatitis or HIV, due to improper handling of instruments.

However, recent scientific literature has shifted the focus to the long-term toxicological and oncological implications of the ink’s components, offering very concerning data on its association with specific tumors, particularly lymphoma and certain types of skin cancer.

Epidemiological evidence

Several recent population studies have provided significant data on this clinical correlation.

The most extensive analysis to date, published in the journal eClinicalMedicine in 2024 and conducted in Sweden, compared 1,398 people with lymphoma against 4,193 healthy individuals.

After adjusting the data for age and lifestyle factors, the researchers determined that tattooed individuals had a 21% higher relative risk of developing lymphoma, although this overall figure was not statistically significant.

However, much more robust associations were observed for specific subtypes of the disease, such as follicular lymphomas and diffuse large B-cell lymphomas.

In order to isolate confounding variables, a 2025 Danish study that included 2,367 twins and analyzed 316 pairs in which one individual was tattooed and the other was not, corroborated and expanded these findings.

The results revealed that, at an individual level, people with tattoos had a significantly higher risk than in the aforementioned study: a 62% greater likelihood of developing skin cancer, including melanoma and squamous cell carcinoma.

A key factor was the “exposure burden” or size of the tattoo: larger tattoos were associated with up to a 2.7 times greater risk of lymphoma and more than double the risk of developing skin tumors.

The persistence of this association among twins, where genetic variation is minimal, indicates that shared genetic or lifestyle factors do not fully explain the increased risk.

It is necessary to point out, following the warnings of epidemiologists and researchers, that current evidence demonstrates an epidemiological association, but does not yet establish a definitive causal relationship.

The researchers acknowledge that these studies may have residual biases and not fully measured confounding factors, such as smoking, sun exposure, or even greater general access to the health system among these individuals.

Biological and Toxicological Mechanisms

The pathophysiological hypothesis for this association is that tattoo ink does not remain isolated in the dermis. Immune cells phagocytize the pigment particles and transport them to the lymphatic system, where they accumulate in regional lymph nodes and can remain biologically active for years or decades.

As we have previously published in our Observatory, previous analyses have revealed that tattoo inks are extremely complex chemical mixtures.

A study published in Scientific Reports identified organic pigments, titanium dioxide, and heavy metals such as chromium, cobalt, manganese, and nickel in lymphatic tissues from human cadavers.

Other assessments have also detected lead, cadmium, azo dyes, and polycyclic aromatic hydrocarbons. Many of these substances are classified as known or suspected carcinogens and can degrade over time, releasing highly toxic compounds.

At a microscopic level, these substances often appear as ultrafine nanoparticles capable of crossing cell barriers and inducing oxidative stress, cell damage, and immune-related alterations.

The prolonged presence and chronic deposits of these pigments cause sustained immune activation or a chronic low-grade inflammatory response.

Furthermore, it should be noted that attempts to reverse exposure through laser removal exacerbate the toxicological risk: the laser fragments the particles, facilitating their systemic dissemination, and chemically alters the pigments, which can trigger new levels of toxicity.

Bioethical and regulatory considerations

The spread of tattooing, which has evolved from being purely aesthetic and anecdotal to constituting a potential public health risk, has raised alarms at the institutional level.

Given this situation, the European Commission’s Joint Research Centre, the European Commission’s science and knowledge service already highlighted in 2020 the urgent need to carry out a thorough and comprehensive risk assessment associated with the chemical ingredients used in inks.

This review should consider critical toxicological parameters such as phototoxicity, absorption levels, distribution in the body and the No Derived Effect Level (DNEL), variables that, for the most part, remain unquantified at present.

To address this lack of control and adequately tackle the risks arising from chemicals, stricter regulatory frameworks were implemented.

Specifically, through Regulation (EU) 2020/2081, framed within the REACH regulations (Registration, Evaluation, Authorization and Restriction of Chemicals), rigorous restrictions were established with harmonized application in all Member States of the European Union.

This regulation precisely governs the use of substances and chemical mixtures intended for the formulation of inks for tattoos and permanent makeup.

From a bioethical perspective, the widespread use of a cosmetic procedure is ethically unacceptable if it does not offer reasonable guarantees of biosafety.

The lack of conclusive data and regulation creates a serious conflict regarding informed consent: users submit to this practice from a position of technical ignorance, which prevents the exercise of responsible autonomy and hinders the assessment of long-term risks.

This scenario of vulnerability is particularly critical in the underage population, where the legal incapacity to make decisions is added.

Available epidemiological and toxicological data support a clear association between tattoos and a higher incidence of lymphoma and skin cancer.

Although causal clinical research is still required to fully unravel the underlying lymphatic and inflammatory mechanisms, the systemic presence of heavy metals and carcinogenic compounds derived from tattoo inks cannot be considered harmless.

This evidence urges health authorities to promote strict regulation and to warn the public about the possible severe oncological effects that, when manifested in the long term, could be irreversible.

The normalization of tattoos is due to the fact that not enough information has been provided about the risks to which potential users are exposed, some of which are potentially very serious, exposing them to avoidable health problems. Because of this, health systems may have to provide costly treatments to these people at the expense of others with different care needs.